Last reviewed · How we verify
Isoflurane Inhalational Sedation
At a glance
| Generic name | Isoflurane Inhalational Sedation |
|---|---|
| Sponsor | Charles University, Czech Republic |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Hypotension
- Nausea
- Vomiting
- Tachycardia
- Bradycardia
- Chills
- Gastrooesophageal reflux disease
- Oropharyngeal pain
- Hyperhidrosis
- Respiratory distress
- Stridor
Key clinical trials
- Reduction of Muscle Catabolism Through Brain Activation in Burn Patients (NA)
- Safety and Efficacy of Inhaled Sedation in Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NA)
- Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER) (NA)
- Inhalational Sedation and Mechanical Power (NA)
- Inhalational Anesthesia and Precipitation of Dementia: is There a Link? (NA)
- Different Volatile Anaesthetics and the Depth of Long Term ICU Sedation (NA)
- Automated Control of End-tidal Volatile Anesthetic Concentration (NA)
- Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isoflurane Inhalational Sedation CI brief — competitive landscape report
- Isoflurane Inhalational Sedation updates RSS · CI watch RSS
- Charles University, Czech Republic portfolio CI